Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-22-035689
Filing Date
2022-06-09
Accepted
2022-06-09 21:21:28
Documents
2
Period of Report
2022-06-07

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4093
2 POA DOCUMENT poa.txt EX-24 2993
  Complete submission text file 0001209191-22-035689.txt   8485
Mailing Address 805 LAS CIMAS PARKWAY SUITE 100 AUSTIN TX 78746
Business Address 805 LAS CIMAS PARKWAY SUITE 100 AUSTIN TX 78746 (512) 942-2935
Aeglea BioTherapeutics, Inc. (Issuer) CIK: 0001636282 (see all company filings)

EIN.: 464312787 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O PTC THERAPEUTICS, INC. 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080
Business Address
Souza Marcio (Reporting) CIK: 0001707657 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37722 | Film No.: 221007458